S 2562
107th Congress
Senate
Health
Agriculture and Food
Ambulatory care
Animal genetics
Animals
Clinical trials
Congress
Congressional investigations
Congressional reporting requirements
Department of Health and Human Services
Digestive diseases
Drug therapy
Education
Environmental Protection
Environmental health
Epidemiology
Genetic research
Government Operations and Politics
Governmental investigations
Health education
Inflammatory Bowel Disease Act
Introduced: May 23, 2002
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 23, 2002
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4852)
May 23, 2002
Sponsor introductory remarks on measure. (CR S4851-4852)
May 23, 2002
Introduced in Senate
Plain-English summary
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.
Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.
Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.
Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4852)
Committees of jurisdiction
1